Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - TOTAL OTHER INCOME
Total Other Income SGMO - Sangamo Therapeutics, Inc.
11.1 M
LAST VALUE
44.11%
2 YEAR CAGR
6.09%
5 YEAR CAGR
63.36%
10 YEAR CAGR